VR Logo

Ajanta Pharma Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1979

Chairman: Mannalal B Agrawal

Managing Director: Yogesh M Agrawal

Group: Vimal Agrawal

Listing: NSE: AJANTPHARM, BSE: 532331

Headquarters: Mumbai, Maharashtra

Website: www.ajantapharma.com

Key Facts

Market cap: R 12,587.00 Cr

Revenue (TTM): R 2,587.87 Cr

Earnings (TTM): R 467.70 Cr

Cash: R 165.25 Cr

Total Debt: R 35.96 Cr

Promoters' ownership: 70.50%

Liquidity: High

52 Week range: R 825.00 - 1,580.00

Face value: R2.00

Shares outstanding: 8,72,61,270

10 Years Aggregate:

  • CFO: 2,578.26 Cr
  • EBITDA: 3,897.52 Cr
  • Net Profit: 2,595.88 Cr

Stock Performance

Time Period Ajanta Pharma S&P BSE Healthcare* S&P BSE Mid Cap*
YTD48.1916.99-18.78
1 month-2.892.471.20
3 months3.5516.55-16.73
1 Year37.7717.97-19.37
3 Years-3.514.61-6.12
5 Years-1.51-0.882.56
10 Years49.8611.086.07
As on 02-Jun-2020 *As on 01-Jun-2020
Year Ajanta Pharma S&P BSE Mid Cap S&P BSE Healthcare
2019-17.53-3.05-3.55
2018-20.40-13.31-5.89
2017-16.3448.130.49
201633.857.97-12.88
201541.197.4315.06
2014145.6154.6947.43
2013269.10-5.7322.55